HomeTrialNCT07225556
🔬NCT07225556Phase 1RECRUITING

A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise Healthy

Study Summary

The purpose of this study is to look at how safe and well-tolerated LY4167586 is in participants with obesity or overweight who are otherwise healthy. Blood tests will be performed to check how much LY4167586 gets into the bloodstream and how long it takes the body to eliminate it following a single administration. Participation in the study will last approximately 7 months.

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment84 participants
Primary Completion
Lead SponsorEli Lilly and Company
Data Retrieved2026-04-11 02:55:33.865779+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.